Avomeen Analytical Services announces that David W. Riggs, PE will take the role of president of the company.
Avomeen Analytical Services announced on April 7, 2015 that it would appoint David W. Riggs as president of the company. Riggs will join Avomeen with almost 30 years of experience in advanced analytical chemistry, product development, chemical engineering, and other roles within the industry.
“David brings excellent credentials into our growing laboratory; his dedication to building successful relationships with clients through long-term mutually beneficial business partnerships is to be admired. He has the vision and ambition to take Avomeen to the next level and comes highly recommended from within the industry. David brings to Avomeen his experience with sales integrations, acquisitions, and the launch of new testing opportunities,” said Shri Thanedar, PhD, CEO of Avomeen Analytical Services, in a press release.
Avomeen is a full-service chemical testing laboratory with product testing and formulation development services. The company specializes in deformulation analysis (reverse engineering), product development, stability testing, pharmaceutical research and development, litigation support services, and pharmaceutical product lifecycle support.
Source: Avomeen
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.